J&J's Litigation Bravado In Sharp Relief After Epic Opioid Trial

Published: 20/09/2019
J&J's Litigation Bravado In Sharp Relief After Epic Opioid Trial
Source: WWW.LAW360.COM

Johnson & Johnson's decision this year to risk a $17 billion penalty in the nation's first opioid-crisis trial added one of the most dramatic chapters yet to the company's increasingly remarkable willingness to spurn settlements and litigate financially perilous cases all the way.

Read more
Related news
Comment
FACEBOOK